InvestingUpdated 2026-03-01

Will Cannabis Stocks Go Up?

Cannabis stock performance depends heavily on federal regulatory progress, company fundamentals, and market sentiment — catalysts like rescheduling or SAFE Banking could drive significant upside.

Predicting whether cannabis stocks will go up involves analyzing several key catalysts and headwinds that will shape the sector's trajectory. While no one can guarantee future stock performance, understanding these factors helps investors assess the probability and magnitude of potential moves.

The single largest catalyst for cannabis stocks is federal regulatory reform. The DEA's rescheduling process to move cannabis from Schedule I to Schedule III would eliminate Section 280E, which currently prevents cannabis companies from deducting ordinary business expenses and results in effective tax rates of 50-70%. Removing this burden could immediately improve cash flows by 2-3x for profitable operators. The SAFE Banking Act, which would allow financial institutions to serve cannabis businesses without federal penalties, would reduce operating costs and open the door to institutional capital.

On the fundamental side, many leading MSOs have demonstrated improving financial metrics. Same-store sales growth, expanding margins, and positive free cash flow generation at companies like Green Thumb Industries and Trulieve suggest that the best operators are building sustainable businesses despite regulatory headwinds. New state market openings — particularly large-population states transitioning from medical-only to adult-use programs — provide organic growth runways.

Headwinds remain significant, however. Oversupply in mature markets like California, Oregon, and Colorado has compressed wholesale prices. Illicit market competition continues to undercut legal operators, particularly in states with high tax rates. Many cannabis companies carry substantial debt loads and have limited access to capital markets, and continued share dilution erodes per-share value for existing shareholders.

The consensus among cannabis analysts is that the sector offers asymmetric upside if key regulatory catalysts materialize, but the timing remains uncertain. Investors should focus on companies with strong balance sheets and proven profitability that can survive an extended period without federal reform while being positioned to benefit when it eventually occurs.

Sources

  • 1.DEA rescheduling proceeding updates
  • 2.Congressional SAFE Banking Act status
  • 3.Cannabis industry analyst reports

Disclaimer: The information provided is for educational purposes only and does not constitute financial, legal, or medical advice. Cannabis stocks carry significant risk including regulatory, legal, and market risks. Cannabis laws vary by jurisdiction. Always consult qualified professionals before making investment, legal, or medical decisions.